arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

agilon health, inc.

AGL
$95.85 ▲ +9.27 (+10.71%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
25 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

agilon health, inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield
Revenue Growth -7.3%
Op. Margin 0.3%
ROIC 26.1%
FCF / Share $1.24
Trailing P/E 32.5x
Price / Book
FCF Yield 1.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.42B
↓ -7.3%
Net Income Profit after all expenses
$48.92M
↑ +303.9%
Operating Margin Operating profit as % of sales
0.3%
↑ +102.3% 17th
FCF / Share Free cash flow per share
$1.24
↑ +196.6%
Long-Term Debt Long-term obligations
$15.28M
↓ -56.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
19
Financial Health
14
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters